Key statistics
On Friday, Oruka Therapeutics Inc (HQ1:FRA) closed at 26.00, 51.52% above the 52 week low of 17.16 set on Feb 02, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 26.00 |
---|---|
High | 26.00 |
Low | 26.00 |
Bid | 27.20 |
Offer | 27.60 |
Previous close | 25.60 |
Average volume | 61.40 |
---|---|
Shares outstanding | 35.00m |
Free float | 34.92m |
P/E (TTM) | -- |
Market cap | 1.04bn USD |
EPS (TTM) | -5.97 USD |
Data delayed at least 15 minutes, as of Oct 18 2024 07:06 BST.
More ▼
Announcements
- Oruka Therapeutics Announces Preclinical Data for ORKA-001 at the European Academy of Dermatology and Venereology Congress
- Oruka Therapeutics Announces $200 Million Private Placement
- Oruka Therapeutics Announces Accelerated Clinical Timelines and Upcoming Presentation at EADV Supporting ORKA-001’s Profile as a Potentially Best-in-Class Half-Life Extended Antibody Targeting IL-23p19
- Oruka Therapeutics Announces Closing of Merger with ARCA biopharma and Previously Announced Private Placement of $275 Million